TrialOncotarget2014

Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway.

Jennifer J Wheler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.